Dow Chemical Company (The) (DOW) Position Boosted by Savant Capital LLC

Savant Capital LLC increased its position in Dow Chemical Company (The) (NYSE:DOW) by 4.6% during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 5,256 shares of the basic materials company’s stock after buying an additional 230 shares during the period. Savant Capital LLC’s holdings in Dow Chemical Company (The) were worth $334,000 as of its most recent filing with the SEC.

Other institutional investors also recently modified their holdings of the company. Bank of New York Mellon Corp raised its stake in shares of Dow Chemical Company (The) by 0.8% in the first quarter. Bank of New York Mellon Corp now owns 16,540,923 shares of the basic materials company’s stock worth $1,051,010,000 after buying an additional 130,524 shares during the last quarter. Ameriprise Financial Inc. raised its stake in shares of Dow Chemical Company (The) by 26.8% in the first quarter. Ameriprise Financial Inc. now owns 10,592,146 shares of the basic materials company’s stock worth $674,160,000 after buying an additional 2,237,295 shares during the last quarter. Norges Bank acquired a new stake in shares of Dow Chemical Company (The) during the fourth quarter worth approximately $327,158,000. UBS Asset Management Americas Inc. raised its stake in shares of Dow Chemical Company (The) by 3.8% in the first quarter. UBS Asset Management Americas Inc. now owns 4,231,431 shares of the basic materials company’s stock worth $268,865,000 after buying an additional 154,721 shares during the last quarter. Finally, Aristotle Capital Management LLC raised its stake in shares of Dow Chemical Company (The) by 0.8% in the fourth quarter. Aristotle Capital Management LLC now owns 4,195,770 shares of the basic materials company’s stock worth $240,082,000 after buying an additional 34,230 shares during the last quarter. 68.79% of the stock is currently owned by hedge funds and other institutional investors.

Dow Chemical Company (NYSE:DOW) opened at 63.26 on Friday. The company has a market capitalization of $77.40 billion, a P/E ratio of 27.09 and a beta of 1.13. The company has a 50 day moving average price of $64.62 and a 200-day moving average price of $63.06. Dow Chemical Company has a 52 week low of $51.57 and a 52 week high of $67.50.

Dow Chemical Company (The) (NYSE:DOW) last posted its quarterly earnings data on Thursday, July 27th. The basic materials company reported $1.08 EPS for the quarter, topping the Zacks’ consensus estimate of $1.01 by $0.07. Dow Chemical Company (The) had a return on equity of 17.08% and a net margin of 5.83%. The firm had revenue of $13.83 billion for the quarter, compared to analyst estimates of $13.60 billion. During the same quarter last year, the company earned $0.95 EPS. The company’s revenue was up 15.7% on a year-over-year basis. On average, equities analysts anticipate that Dow Chemical Company will post $4.08 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Monday, October 2nd. Shareholders of record on Monday, July 31st will be paid a dividend of $0.46 per share. The ex-dividend date is Thursday, July 27th. This represents a $1.84 dividend on an annualized basis and a yield of 2.91%. Dow Chemical Company (The)’s dividend payout ratio (DPR) is presently 76.99%.

TRADEMARK VIOLATION NOTICE: “Dow Chemical Company (The) (DOW) Position Boosted by Savant Capital LLC” was published by Community Financial News and is the property of of Community Financial News. If you are reading this piece on another domain, it was copied illegally and republished in violation of US and international trademark and copyright legislation. The legal version of this piece can be read at https://www.com-unik.info/2017/08/12/dow-chemical-company-the-dow-shares-bought-by-savant-capital-llc-updated-updated.html.

A number of equities research analysts have commented on the company. UBS AG restated a “buy” rating and set a $72.00 price objective on shares of Dow Chemical Company (The) in a research report on Monday, May 15th. Credit Suisse Group set a $66.00 price target on Dow Chemical Company (The) and gave the company a “buy” rating in a report on Sunday, April 30th. BidaskClub lowered Dow Chemical Company (The) from a “sell” rating to a “strong sell” rating in a report on Thursday. Zacks Investment Research upgraded Dow Chemical Company (The) from a “hold” rating to a “buy” rating and set a $68.00 price target for the company in a report on Tuesday, April 18th. Finally, Cowen and Company lifted their price target on Dow Chemical Company (The) from $47.00 to $60.00 and gave the company a “market perform” rating in a report on Wednesday, May 31st. Two analysts have rated the stock with a sell rating, three have given a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Dow Chemical Company (The) presently has an average rating of “Buy” and an average target price of $71.42.

About Dow Chemical Company (The)

Institutional Ownership by Quarter for Dow Chemical Company (The) (NYSE:DOW)

What are top analysts saying about Dow Chemical Company (The)? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Dow Chemical Company (The) and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit